|4Dec 7, 9:00 AM ET

Jafri Hasan 4

4 · Aridis Pharmaceuticals, Inc. · Filed Dec 7, 2022

Insider Transaction Report

Form 4
Period: 2022-12-05
Jafri Hasan
Chief Medical Officer
Transactions
  • Award

    Restricted Stock Units

    2022-12-05+20,00020,000 total
    Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]10,000 shares of Common Stock will vest on June 5, 2023 and 10,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.

Documents

1 file
  • 4
    ownership.xmlPrimary